 Gongyi Zhang
Concepts (166)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Histone Demethylases | 3 | 2020 | 28 | 2.000 |
Why?
| | Spike Glycoprotein, Coronavirus | 3 | 2022 | 94 | 1.720 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 3 | 2018 | 59 | 1.560 |
Why?
| | Arginine | 3 | 2022 | 249 | 1.050 |
Why?
| | Histones | 3 | 2020 | 552 | 1.000 |
Why?
| | Positive Transcriptional Elongation Factor B | 2 | 2020 | 22 | 0.930 |
Why?
| | Antibodies, Monoclonal, Humanized | 3 | 2022 | 667 | 0.870 |
Why?
| | Protein-Arginine N-Methyltransferases | 1 | 2022 | 14 | 0.850 |
Why?
| | RNA Polymerase II | 2 | 2020 | 282 | 0.760 |
Why?
| | Cyclin-Dependent Kinase 9 | 1 | 2020 | 9 | 0.760 |
Why?
| | Hydrogen Bonding | 2 | 2017 | 146 | 0.740 |
Why?
| | Myeloid-Lymphoid Leukemia Protein | 1 | 2020 | 64 | 0.700 |
Why?
| | Methyltransferases | 1 | 2020 | 61 | 0.700 |
Why?
| | Mutation | 5 | 2022 | 3457 | 0.690 |
Why?
| | Glycoproteins | 4 | 2014 | 319 | 0.680 |
Why?
| | Phosphoproteins | 4 | 2014 | 308 | 0.670 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2020 | 181 | 0.640 |
Why?
| | Receptors, Cell Surface | 1 | 2020 | 367 | 0.630 |
Why?
| | Leukemia | 1 | 2020 | 208 | 0.630 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2020 | 317 | 0.620 |
Why?
| | Cytidine Deaminase | 1 | 2017 | 57 | 0.610 |
Why?
| | Sirtuin 2 | 1 | 2017 | 13 | 0.600 |
Why?
| | Sirtuins | 1 | 2017 | 34 | 0.590 |
Why?
| | Protein Folding | 1 | 2017 | 250 | 0.560 |
Why?
| | Protein Conformation | 6 | 2018 | 848 | 0.550 |
Why?
| | Protein Binding | 5 | 2021 | 1975 | 0.550 |
Why?
| | Antiviral Agents | 1 | 2021 | 654 | 0.520 |
Why?
| | Protein Structure, Tertiary | 3 | 2020 | 823 | 0.510 |
Why?
| | Methylation | 3 | 2022 | 204 | 0.500 |
Why?
| | Protein Unfolding | 1 | 2014 | 34 | 0.500 |
Why?
| | Urea | 1 | 2014 | 77 | 0.490 |
Why?
| | Transcription, Genetic | 1 | 2020 | 1323 | 0.490 |
Why?
| | beta Catenin | 1 | 2014 | 219 | 0.440 |
Why?
| | Binding Sites | 4 | 2021 | 1224 | 0.390 |
Why?
| | Staphylococcus aureus | 2 | 2006 | 394 | 0.390 |
Why?
| | Protein Processing, Post-Translational | 3 | 2018 | 408 | 0.380 |
Why?
| | Lipids | 1 | 2014 | 607 | 0.380 |
Why?
| | Crystallography, X-Ray | 4 | 2018 | 422 | 0.370 |
Why?
| | Antibodies, Neutralizing | 2 | 2022 | 228 | 0.360 |
Why?
| | Ligands | 3 | 2022 | 567 | 0.350 |
Why?
| | Immunity, Innate | 2 | 2014 | 745 | 0.340 |
Why?
| | Bacterial Proteins | 2 | 2006 | 759 | 0.340 |
Why?
| | Models, Molecular | 4 | 2018 | 1435 | 0.300 |
Why?
| | Protein Denaturation | 2 | 2017 | 73 | 0.280 |
Why?
| | Animals | 13 | 2022 | 33381 | 0.270 |
Why?
| | RNA | 1 | 2010 | 833 | 0.240 |
Why?
| | Humans | 19 | 2023 | 118974 | 0.230 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2004 | 147 | 0.230 |
Why?
| | Antigens | 2 | 2015 | 320 | 0.230 |
Why?
| | Vaccines, Synthetic | 1 | 2022 | 128 | 0.210 |
Why?
| | DNA Helicases | 1 | 2023 | 131 | 0.210 |
Why?
| | Immunity, Humoral | 1 | 2022 | 117 | 0.200 |
Why?
| | DNA Replication | 1 | 2023 | 211 | 0.200 |
Why?
| | Mice | 9 | 2020 | 15520 | 0.200 |
Why?
| | Antigen-Antibody Reactions | 1 | 2021 | 51 | 0.200 |
Why?
| | Peptide Hydrolases | 1 | 2022 | 108 | 0.200 |
Why?
| | Surface Plasmon Resonance | 1 | 2021 | 85 | 0.190 |
Why?
| | Receptors, Virus | 1 | 2021 | 78 | 0.190 |
Why?
| | Molecular Docking Simulation | 1 | 2021 | 101 | 0.190 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2021 | 138 | 0.180 |
Why?
| | Blotting, Western | 2 | 2020 | 1194 | 0.180 |
Why?
| | Gene Knockout Techniques | 1 | 2020 | 105 | 0.180 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2022 | 404 | 0.170 |
Why?
| | Protein Domains | 1 | 2020 | 212 | 0.170 |
Why?
| | Pneumonia, Mycoplasma | 2 | 2010 | 33 | 0.170 |
Why?
| | Amino Acids | 1 | 2022 | 465 | 0.170 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2004 | 1171 | 0.170 |
Why?
| | Nucleosomes | 1 | 2020 | 131 | 0.170 |
Why?
| | tat Gene Products, Human Immunodeficiency Virus | 1 | 2018 | 21 | 0.160 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2018 | 58 | 0.160 |
Why?
| | Host-Pathogen Interactions | 1 | 2021 | 300 | 0.160 |
Why?
| | Kinetics | 1 | 2021 | 1624 | 0.150 |
Why?
| | Proline | 1 | 2017 | 71 | 0.150 |
Why?
| | Proteolysis | 1 | 2018 | 146 | 0.150 |
Why?
| | Acylation | 1 | 2017 | 28 | 0.150 |
Why?
| | Mass Spectrometry | 1 | 2020 | 681 | 0.140 |
Why?
| | Catalysis | 1 | 2017 | 295 | 0.140 |
Why?
| | Fibroblasts | 2 | 2018 | 842 | 0.140 |
Why?
| | DNA-Binding Proteins | 1 | 2003 | 1346 | 0.140 |
Why?
| | Wound Healing | 1 | 2018 | 270 | 0.140 |
Why?
| | Cells, Cultured | 4 | 2018 | 4077 | 0.140 |
Why?
| | Phosphorylation | 1 | 2020 | 1633 | 0.140 |
Why?
| | Promoter Regions, Genetic | 1 | 2020 | 1158 | 0.140 |
Why?
| | Signal Transduction | 2 | 2010 | 4709 | 0.130 |
Why?
| | Hybridomas | 1 | 2015 | 233 | 0.130 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 1 | 2015 | 82 | 0.130 |
Why?
| | Lysine | 1 | 2017 | 248 | 0.130 |
Why?
| | HEK293 Cells | 2 | 2014 | 625 | 0.130 |
Why?
| | RNA, Messenger | 1 | 2022 | 2657 | 0.130 |
Why?
| | Circular Dichroism | 1 | 2014 | 139 | 0.120 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 1 | 2014 | 102 | 0.120 |
Why?
| | Cell Movement | 1 | 2018 | 896 | 0.120 |
Why?
| | DNA Primers | 1 | 2014 | 533 | 0.110 |
Why?
| | Cell Proliferation | 2 | 2018 | 2275 | 0.110 |
Why?
| | Mice, Knockout | 2 | 2017 | 2680 | 0.110 |
Why?
| | Cell Line, Tumor | 1 | 2020 | 2851 | 0.110 |
Why?
| | Epigenesis, Genetic | 1 | 2017 | 539 | 0.110 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2014 | 240 | 0.110 |
Why?
| | Base Sequence | 2 | 2014 | 2159 | 0.110 |
Why?
| | Sulfhydryl Compounds | 1 | 2014 | 179 | 0.110 |
Why?
| | Water | 1 | 2014 | 425 | 0.100 |
Why?
| | Immunoglobulin G | 1 | 2015 | 788 | 0.100 |
Why?
| | Respiratory Mucosa | 2 | 2010 | 254 | 0.100 |
Why?
| | Dimerization | 2 | 2014 | 183 | 0.100 |
Why?
| | TNF Receptor-Associated Factor 2 | 1 | 2010 | 8 | 0.100 |
Why?
| | TRPC Cation Channels | 1 | 2010 | 11 | 0.100 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2010 | 79 | 0.090 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2010 | 76 | 0.090 |
Why?
| | RNA, Double-Stranded | 1 | 2010 | 46 | 0.090 |
Why?
| | Binding, Competitive | 1 | 2010 | 205 | 0.090 |
Why?
| | B-Lymphocytes | 1 | 2015 | 770 | 0.090 |
Why?
| | Toll-Like Receptor 2 | 1 | 2010 | 127 | 0.090 |
Why?
| | Eosinophils | 1 | 2012 | 282 | 0.090 |
Why?
| | Peptide Fragments | 1 | 2014 | 702 | 0.090 |
Why?
| | Substrate Specificity | 1 | 2010 | 371 | 0.090 |
Why?
| | DNA, Single-Stranded | 1 | 2010 | 114 | 0.090 |
Why?
| | Molecular Sequence Data | 3 | 2010 | 2871 | 0.080 |
Why?
| | Mycoplasma pneumoniae | 1 | 2007 | 33 | 0.080 |
Why?
| | Respiratory Hypersensitivity | 1 | 2007 | 65 | 0.080 |
Why?
| | Nucleic Acid Conformation | 1 | 2010 | 670 | 0.070 |
Why?
| | Pneumonia | 1 | 2012 | 592 | 0.070 |
Why?
| | Helix-Turn-Helix Motifs | 1 | 2006 | 3 | 0.070 |
Why?
| | Cations, Divalent | 1 | 2006 | 52 | 0.070 |
Why?
| | Amino Acid Sequence | 2 | 2010 | 2071 | 0.070 |
Why?
| | Conserved Sequence | 1 | 2006 | 219 | 0.070 |
Why?
| | Virulence | 1 | 2006 | 240 | 0.060 |
Why?
| | Inflammation Mediators | 1 | 2007 | 502 | 0.060 |
Why?
| | Insulin | 1 | 2014 | 2162 | 0.060 |
Why?
| | DNA | 1 | 2010 | 1388 | 0.060 |
Why?
| | Proliferating Cell Nuclear Antigen | 1 | 2023 | 55 | 0.060 |
Why?
| | Homologous Recombination | 1 | 2023 | 22 | 0.060 |
Why?
| | Crystallization | 1 | 2003 | 146 | 0.060 |
Why?
| | Molecular Structure | 1 | 2004 | 459 | 0.050 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2003 | 178 | 0.050 |
Why?
| | Protein Structure, Secondary | 1 | 2003 | 338 | 0.050 |
Why?
| | DNA, Bacterial | 1 | 2003 | 314 | 0.050 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2003 | 279 | 0.050 |
Why?
| | Keratinocytes | 1 | 2018 | 227 | 0.040 |
Why?
| | Recombinant Proteins | 2 | 2012 | 1308 | 0.040 |
Why?
| | Transcription Factors | 1 | 2003 | 1570 | 0.030 |
Why?
| | Skin | 1 | 2018 | 657 | 0.030 |
Why?
| | Chemokine CCL24 | 1 | 2012 | 9 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2014 | 574 | 0.030 |
Why?
| | Ovalbumin | 1 | 2012 | 165 | 0.030 |
Why?
| | Interleukin-13 | 1 | 2012 | 135 | 0.030 |
Why?
| | Interleukin-4 | 1 | 2012 | 215 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2014 | 940 | 0.020 |
Why?
| | Th2 Cells | 1 | 2012 | 164 | 0.020 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2010 | 363 | 0.020 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2012 | 613 | 0.020 |
Why?
| | Macrophages, Alveolar | 1 | 2012 | 359 | 0.020 |
Why?
| | Lipopolysaccharides | 1 | 2012 | 870 | 0.020 |
Why?
| | Lipoproteins | 1 | 2007 | 162 | 0.020 |
Why?
| | Interleukin-8 | 1 | 2007 | 249 | 0.020 |
Why?
| | RNA Interference | 1 | 2007 | 460 | 0.020 |
Why?
| | Epithelial Cells | 1 | 2010 | 963 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2007 | 1206 | 0.020 |
Why?
| | Up-Regulation | 1 | 2007 | 872 | 0.020 |
Why?
| | Models, Biological | 1 | 2010 | 1715 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2012 | 4908 | 0.010 |
Why?
| | Cell Line | 1 | 2007 | 2707 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2010 | 2445 | 0.010 |
Why?
| | Lung | 1 | 2012 | 3664 | 0.010 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2014 | 3360 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2007 | 3730 | 0.010 |
Why?
| | Female | 2 | 2014 | 61565 | 0.010 |
Why?
|
|
Zhang's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|